Aurigene Pharmaceutical Services Ltd.

Aurigene is a contract research, development and manufacturing organization offering truly integrated CRO (discovery) and CDMO services for the small and large molecules to global innovative pharma and biotech companies.
Beyond science, our operations are rooted in the fundamental principles of compliance, information security, quality, and sustainability. As an environmentally responsible company, we continue delivering on our ESG goals. We became water-positive in 2023 and are working on ambitious goals to reduce our carbon footprint. In numbers, we aim to switch to 100% renewable power by 2030 and achieve carbon neutrality in our direct operations (Scope 1 and Scope 2 emissions) by 2030 and a 12.5% reduction in indirect carbon emissions across our supply chain (Scope 3 emissions) by 2030.